Patient and consumer advocacy groups criticized proposed device user fees as being too low and stressed the need for additional funding for post-market surveillance programs during a March 28 public meeting on device user fee reauthorization.
Under the medical device user fee agreement, reached by FDA and industry negotiators in February, the agency would collect $595...